B
Benitec Biopharma D
D
BNTC
13.570
USD
-0.15
(-1.09%)
مغلق
حجم التداول
2,111
الربح لكل سهم
-2
العائد الربحي
-
P/E
-22
حجم السوق
346,663,128
العنوان: Benitec Biopharma
القطاع: Healthcare
الصناعة: Biotechnology
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.